-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322. Disorders of Coagulation or Fibrinolysis: Poster II

Disorders of Coagulation or Fibrinolysis Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Víctor Jiménez-Yuste, Dr1*, Johannes Oldenburg, MD, PhD2, Savita Rangarajan, MBBS, FRCP, FRCPath3, Roser Peiró, PhD4* and Elena Santagostino, MD, PhD5*

1Haematology Department, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain
2Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany
3The Centre for Haemostasis and Thrombosis, St Thomas' Hospital, London, United Kingdom
4Scientific and Medical Affairs, Grifols, Sant Cugat del Vallès, Spain
5Centro Emofilia e Trombosi "Angelo Bianchi Bonomi", Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy

Kingsley Hampton1*, Pratima Chowdary2*, Scott Dunkley3*, Silke Ehrenforth, MD, PhD4, Lotte Jacobsen4*, Anne T. Neff, MD5, Elena Santagostino, MD, PhD6, Jameela Sathar7*, Hideyuki Takedani8*, Clifford M. Takemoto, MD9 and Claude Négrier10*

1Department of Cardiovascular Science, University of Sheffield, Sheffield, United Kingdom
2Royal Free Hospital, London, United Kingdom
3Institute of Haematology, Royal Prince Alfred Hospital, Sydney, Australia
4Novo Nordisk, Søborg, Denmark
5Vanderbilt University Medical Center, Nashville, TN
6Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy
7Department of Hematology, Hospital Ampang, Kuala Lumpur, Malaysia
8Department of Joint Surgery, Research Hospital, Institute of Medical Science, University of Tokyo, Tokyo, Japan
9Division of Pediatric Hematology, The Johns Hopkins University, Baltimore, MD
10Department of Haematology, Louis Pradel University Hospital, Bron, France

Panagiotis Anagnostis1*, Sofia Vakalopoulou1*, Dimitrios Christoulas2*, Spyridon Karras3*, Athanasios Papatheodorou4*, Eirini Katodritou5*, Panagiotis Kokkoris4*, Vasilia Garipidou1* and Evangelos Terpos6

1Hemophilia Center of Northern Greece, 2nd Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, School of Medicine, Hippokration Hospital, Thessaloniki, Greece
2Department of Hematology, 251 General Air Force Hospital, Athens, Greece
3Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, School of Medicine, ‘‘Papageorgiou’’ General Hospital, Thessaloniki, Greece
4Department of Medical Research, 251 General Air Force Hospital, Athens, Greece
5Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
6Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Peter H. Cygan, MD1, Laura Carrel, Ph.D2* and M. Elaine Eyster, MD1

1Department of Medicine, Division of Hematology/Oncology, Penn State Hershey Medical Center, Hershey, PA
2Department of Biochemistry and Molecular Biology, Penn State College of Medicine, Hershey, PA

Maitri Kalra, MBBS1, Ashish Aggarwal2*, Vikas Kalra1*, Laura Caragol3*, Marwan Ghabril1* and Naveen Manchanda, MBBS4

1Indiana University, Indianapolis, IN
2Community Hospital, Indianapolis, IN
3University of Colorado, Denver, CO
4Simon Cancer Center, IU Hospital, Indianapolis, IN

Yesim G. Dargaud, MD, PhD1, Yohann Jourdy2*, Sandra Le Quellec2*, Coen Hemker3*, Theo Lindhout4*, Elisabetta Castoldi4* and Claude Negrier, MD5

1Hopital Edouard Herriot Pav. E, Lyon, France
2Hopital Edouard Herriot, Lyon, France
3Synapse bv, Maastricht, Netherlands
4University of Maastricht, Maastricht, Netherlands
5Hôpital Edouard Herriot, University Claude Bernard, Lyon, France

Charles T Nakar, MD1, Roberto Caputo, MD2*, Francis W Price Jr., MD3*, Maria Teresa Sartori, MD4*, Andrea Leonardi5*, Anna Lotti Suffredini6*, Neelam Thukral7*, Jacopo Secci2*, Bennie H Jeng, MD8* and Amy D Shapiro, MD9

1Pediatric Hematology, Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
2Pediatric Ophthalmology Unit, A. Meyer Children's Hospital, Florence, Italy
3Price Vision Group, Indianapolis, IN
4Department of Cardiologic, Thoracic and Vascular Sciences, University of Padova, Padova, Italy
5Department of Neuroscience, Ophthalmology Unit, University of Padova, Padova, Italy
6Clinical Development and Operations Group, Kedrion SpA, Lucca, Italy
7Indiana Hemophilia and Thrombosis Center, Indianapolis, IN
8Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD
9Indiana Hemophilia & Thrombosis Center, Indianapolis, IN

Beth Boulden Warren, MD, MS1, Linda Jacobsen, BS2*, Elizabeth Villalobos-Menuey, BS2*, Thomas C. Abshire, MD3, Amy D Shapiro, MD4, Michael Recht, MD, PhD5, Deborah Brown, MD6, Cindy A. Leissinger, MD7, Christine L. Kempton, MD, MSc8, Heidi Lane, PT, DPT, PCS9*, Diane J. Nugent, MD10 and Marilyn J. Manco-Johnson, MD11

1Children's Hospital Colorado, University of Colorado Anschutz Medical Campus, Aurora, CO
2University of Colorado Anschutz Medical Campus, Aurora, CO
3Blood Center of Wisconsin, Milwaukee, WI
4Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
5Ohio State University, Columbus, OH
6Department of Pediatrics- Hematology Division, University of Texas, Houston, TX
7Tulane University School of Medicine, New Orleans, LA
8Department of Pediatrics, Emory University, Atlanta, GA
9University of Utah, Salt Lake City, UT
10Children's Hospital of Orange County, Orange, CA
11Hemophilia and Thrombosis Center, Dept of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO

Pal André Holme, PhD, MD1*, Robert Campbell Tait, MD2*, Christophe Combescure, PhD3*, Erik Berntorp, MD, PhD4, Annarita Tagliaferri5*, Peter Staritz, MD6*, Roger E.G. Schutgens, MD, PhD7, Robert Klamroth8*, Natascha Marquardt9*, Stephan Rauchensteiner10* and Philippe De Moerloose, MD, PhD11*

1Department of Haematology, Oslo University Hospital, Oslo, Norway
2Royal Infirmary, Glasgow, United Kingdom, Glasgow, United Kingdom
33University Hospital and Faculty of Medicine of Geneva, Geneva, Switzerland, Geneva, Switzerland
4Lund University, Malmö, Sweden, Malmö, Sweden
55University Hospital of Parma, Parma, Italy, Parma, Italy
6Kurpfalz Hospital and Hemophilia Center, Heidelberg, Germany, Heidelberg, Germany
7Hematology and Van Creveldkliniek, University Medical Center, Utrecht, Netherlands
8Vivantes Clinic Friedrichshain, Berlin, Germany
9Institute for Experimental Haematology and Transfusion Medicine, University Clinic, Bonn, Germany, Bonn, Germany
10Bayer Healthcare, Berlin, Germany., Berlin, Germany
11University Hospital and Faculty of Medicine of Geneva, Geneva, Switzerland, Geneva, Switzerland

Devi Gunasekera, MBBS1*, Debargh Kumar Dutta, PhD1*, Eddie A. James, Ph.D.2*, Margaret V Ragni3 and Kathleen P. Pratt, Ph.D.1

1Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD
2Benaroya Research Institute, Seattle, WA
3University of Pittsburgh and Hemophilia Center of Western PA, Pittsburgh, PA

Kevin R. Viel, Ph.D.1*, Marco Hofmann, MD, PhD2*, Sabine Zollner2*, Bernadette W. Luu3*, Rajalingam Raja, PhD4*, Jerry Sherman Powell, MD5, Eugene Maraskovsky, M.D., Ph.D.6* and Tom E. Howard, MD, PhD7,8,9*

1Histonis, Inc., Atlanta, GA
2CSL Behring, Marburg, Germany
3Department of Pathology and Laboratory Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA
4Immunogenetics Center, University of California at San Francisco, San Francisco, CA
5CSL Behring, King of Prussia, PA
6CSL Behring, Melbourne, Australia
7Pathology and Laboratory Medicine, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA
8Department of Pathology and Laboratory Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
9Division of Hematology & Oncology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA

Margaret V Ragni1,2, Giancarlo Castaman3,4*, Joan Cox Gill5,6, Peter Kouides7,8*, Miranda Chapman9*, Arthur Sytkowski9*, Ortrun Obermann-Slupetzky10*, Isabella Presch10, Sandor Fritsch10* and Bruce M. Ewenstein9

1Hemophilia Center of Western Pennsylvania, University of Pittsburgh, Pittsburgh, PA
2University of Pittsburgh and Hemophilia Center of Western Pennsylvania, Pittsburgh, PA
3San Bortolo Hospital, Vicenza, Italy
4Center for Bleeding Disorders, Careggi University Hospital, Florence, Italy
5Medical College of Wisconsin, Milwaukee, WI
6BloodCenter of Wisconsin and Medical College of Wisconsin, Milwaukee, WI
7University of Rochester School of Medicine, Rochester, NY
8Mary Gooley Hemophilia Center, Rochester, NY
9Baxalta US Inc., Cambridge, MA
10Baxalta Innovations GmbH, Vienna, Austria

Amy D Shapiro, MD1, David J Perry2, Ross I Baker, MD3, Elisa Tsao4* and Baisong Mei4*

1Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
2Addenbrooke’s Hospital, Cambridge, United Kingdom
3Western Australia Centre for Thrombosis and Haemostasis, Murdoch University, Perth, Australia
4Biogen, Cambridge, MA

Pedro Paz1*, Jens Schroeder2*, Prasad Mathew3, Marion Hardtke2* and Fred Aswad1*

1Global Biologics Research, Lead Discovery, Bayer HealthCare, San Francisco, CA
2Global Clinical Development, Bayer Pharma AG, Berlin, Germany
3Bayer HealthCare Pharmaceuticals, Whippany, NJ

Margaret Carlisle Cupit, BS1, Amulya NageswaraRao, MBBS2*, Deepti M. Warad, M.B.B.S.3,4, Shakila Khan, MD5 and Vilmarie Rodriguez, MD4

1Mayo Medical School, Mayo Clinic, Rochester, MN
2Pediatric Hematology/Oncology, Mayo Clinic, Rochester, MN
3Division of Hematopathology, Special Coagulation Laboratory, Mayo Clinic, Rochester, MN
4Division of Pediatric Hematology and Oncology, Mayo Clinic, Rochester, MN
5Division of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, MN

A. Kathleen Hesselton1*, Michael Mosier2*, Debra Hoppensteadt, PhD1*, Walter Jeske, PhD3* and Jawed Fareed, PhD1

1Department of Pathology, Loyola University Medical Center, Maywood, IL
2Department of Surgery, Loyola University Medical Center, Maywood, IL
3Department of Thoracic and Cardiovascular Surgery, Loyola University Medical Center, Maywood, IL

Claude Negrier, MD1, Lynda Mae Lepatan, MD2*, Faralzah Karim, MD3*, Anne Lienhart, MD1*, Denise Wolko4*, Christine Voigt, PhD4*, Iris C. Jacobs, MD4 and Elena Santagostino, MD, PhD5

1Hôpital Edouard Herriot, University Claude Bernard, Lyon, France
2Perpetual Succour Hospital, Cebu City, Philippines
3National Blood Centre, Haemophilia Centre, Kuala Lumpur, Malaysia
4CRD, CSL Behring, King of Prussia, PA
5Centro Emofilia e Trombosi, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy

Brigitte Brand1, Ralph A. Gruppo, MD2, Tung T. Wynn3, Laimonas Griskevicius4*, Maria Fernanda Lopez Fernandez5*, Thomas Dvorak6*, Lisa Patrone7* and Brigitt E. Abbuehl6

1Universitaetsspital Zuerich, Zeurich, Switzerland
2Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3University of Florida, Gainesville, FL
4Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania
55Complejo Hospitalario Universitario A Coruña, A Coruña, Spain
6Baxalta, Vienna, Austria
7Baxalta, Westlake Village, CA

Marilyn J. Manco-Johnson, MD1, Alice D. Ma, MD2, Robert Klamroth3*, Werner Engl4*, Lorena Griparic, PhD5*, Jacqueline A Dyck-Jones, PhD5* and Brigitt E. Abbuehl4

1Mountain State Regional Hemophilia and Thrombosis Center, University of Colorado Anschutz Medical Campus, Aurora, CO
2Hemophilia Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC
3Vivantes Clinic Friedrichshain, Berlin, Germany
4Baxalta, Vienna, Austria
5Baxalta US Inc., Westlake Village, CA

Haowei (Linda) Sun, MD1, Ming Yang, PhD2*, Afrah S Sait, MD3*, Annette Von Drygalski, MD, PharmD4 and Shannon Jackson5,6

1University of British Columbia, Vancouver, BC, Canada
2British Columbia Provincial Bleeding Disorders Program-Adult Division, Vancouver, BC, Canada
3Department of Medicine, University of British Columbia, Vancouver, BC, Canada
4Division of Hematology/Oncology, Department of Medicine, University of California San Diego, San Diego, CA
5Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada
6St Paul’s Hospital, Vancouver, BC, Canada

Guy Young, MD1, Miguel Escobar2*, Steven Pipe, MD3 and David L. Cooper, MD, MBA4

1Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA
2University of Texas Health Science Center and The Gulf States Hemophilia and Thrombophilia Center at Houston, Houston, TX
3Hemophilia and Coagulation Disorders Program, University of Michigan, Ann Arbor, MI
4Clinical, Medical and Regulatory Affairs, Novo Nordisk Inc., Plainsboro, NJ

Jawed Fareed, PhD1, Debra Hoppensteadt, PhD1*, Daneyal Syed1*, Daniel Kahn1*, Michael Mosier2*, Amanda Walborn1* and Mark Williams3*

1Department of Pathology, Loyola University Medical Center, Maywood, IL
2Department of Surgery, Loyola University Medical Center, Maywood, IL
3Asahi Kasei Pharma America, Waltham, MA

Luigi Solimeno, MD1*, Steven R. Lentz, MD, PhD2, Irina Matytsina, MD3*, Niels Zeuthen4*, Faraizah Abdul Karim, MD5* and Elena Santagostino, MD, PhD6

1Department of Orthopedic Surgery and Traumatology, Ca' Grande Foundation, Maggiore Hosptial Policlinico, Milan, Italy
2University of Iowa Carver College of Medicine, Iowa City, IA
3Novo Nordisk A/S, Soeborg, Denmark
4Novo Nordisk A/S, Søborg, Denmark
5National Blood Center, Kuala Lumpur, Malaysia
6Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Ca' Granda Foundation, Maggiore Hospital Policlinico, Milan, Italy

Elena Varotto1*, Giovanna Sanna1*, Luca Spiezia2*, Stefania Varotto, MD3*, Marta Pillon, MD4*, Laura Sainati, MD1*, Alessandra Todesco1*, Barbara Buldini, MD5*, Maria Grazia Petris1*, Raffaella Colombatti1*, Manuela Tumino1*, Giada Biddeci1*, Antonio Marzollo1*, Maria Gabelli1*, Maria Paola Boaro1*, Elena Campello1*, Paolo Simioni, MD, PhD6*, Giuseppe Basso, Prof, MD5 and Maria Caterina Putti, MD3*

1University of Padua, Department of Women’s and Chidren’s Health, Italy, University of Padua, Padua, Italy
2Department of Internal Medicine, University of Padua, Padua, Italy
3Department of Women’s and Chidren’s Health, University of Padua, Padua, Italy
4Department of Women's and Children's Health, University Hospital of Padova, Clinic of Pediatric Hemato-Oncology, Padova, Italy
5Woman and Child Health Department, University of Padova, Padova, Italy
6Medical & Surgical Sciences, Univ. of Padua, Med. School, Padova, Italy

Bhanu P Gupta, MD, MS1*, Juan Leoni1*, Parag Patel, MD1*, Dong Chen, MD, PhD2 and Joseph Blackshear, MD3*

1Transplant Cardiology, Mayo Clinic, Jacksonville, FL
2Hematohology, Mayo Clinic, Rochester, MN
3Cardiovascular Diseases, Mayo Clinic, Jacksonville, FL

Roshni Kulkarni1, Amy D Shapiro, MD2, Jerzy Windyga3*, Margaret V Ragni4, K John Pasi5, Margareth Castro Ozelo, MD, PhD6, Elisa Tsao7* and Baisong Mei7*

1Dept. Of Pediatrics and Human Development, Michigan State University, East Lansing, MI
2Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
3Department of Disorders of Haemostasis and Internal Medicine, Institute of Haematology and Transfusion Medicine, Warsaw, Poland
4University of Pittsburgh and Hemophilia Center of Western PA, Pittsburgh, PA
5Barts and the London Comprehensive Care Center, London, United Kingdom
6INCT do Sangue Hemocentro UNICAMP, Campinas, Brazil
7Biogen, Cambridge, MA

*signifies non-member of ASH